Article
05 May 2025
Trump Administration Issues Drug Pricing Executive Order
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
26 Mar 2025
CMS's ACA Marketplace Integrity And Affordability Proposed Rule – What It Could Mean For Health Plans
Article
21 Mar 2025
What To Take Away From CMMI's Early Termination Of Four Demonstration Models
Article
18 Feb 2025
Mintz IRA Update — A Circuit Win And The End Of Chevron Deference Could Shift Tides In Drug Price Negotiation Program Challenges
Article
21 Nov 2024
Unpacking Johnson & Johnson's Lawsuit Over 340B Rebate Model
Article
04 Nov 2024
Stakeholders Raise 340B Concerns In Medicaid Drug Rebate Program Final Rule; CMS, With Hands Tied, Shrugs
Article
21 Aug 2024
CMS 2026 IRA Price Negotiations Results Likely To Create Upstream And Downstream Effects
Article
18 Jul 2024
IRA Litigation Update: Courts Begin To Address Legal Challenges To The Medicare Drug Price Negotiation Program
Article
15 Jul 2024
Special Edition: FTC 6(b) Interim Staff Report And Activity
Article
12 Jul 2024
The Uncertain Landscape Of Medicare Agent/Broker Compensation Rules